ID   AIMP2_HUMAN             Reviewed;         320 AA.
AC   Q13155; F8W950; Q75MR1; Q96CZ5; Q9P1L2;
DT   01-NOV-1997, integrated into UniProtKB/Swiss-Prot.
DT   11-JAN-2001, sequence version 2.
DT   18-JUN-2025, entry version 205.
DE   RecName: Full=Aminoacyl tRNA synthase complex-interacting multifunctional protein 2;
DE   AltName: Full=Multisynthase complex auxiliary component p38;
DE   AltName: Full=Protein JTV-1;
GN   Name=AIMP2; Synonyms=JTV1; ORFNames=PRO0992;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RX   PubMed=8666379; DOI=10.1006/geno.1995.9997;
RA   Nicolaides N.C., Kinzler K.W., Vogelstein B.;
RT   "Analysis of the 5' region of PMS2 reveals heterogeneous transcripts and a
RT   novel overlapping gene.";
RL   Genomics 29:329-334(1995).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=12853948; DOI=10.1038/nature01782;
RA   Hillier L.W., Fulton R.S., Fulton L.A., Graves T.A., Pepin K.H.,
RA   Wagner-McPherson C., Layman D., Maas J., Jaeger S., Walker R., Wylie K.,
RA   Sekhon M., Becker M.C., O'Laughlin M.D., Schaller M.E., Fewell G.A.,
RA   Delehaunty K.D., Miner T.L., Nash W.E., Cordes M., Du H., Sun H.,
RA   Edwards J., Bradshaw-Cordum H., Ali J., Andrews S., Isak A., Vanbrunt A.,
RA   Nguyen C., Du F., Lamar B., Courtney L., Kalicki J., Ozersky P.,
RA   Bielicki L., Scott K., Holmes A., Harkins R., Harris A., Strong C.M.,
RA   Hou S., Tomlinson C., Dauphin-Kohlberg S., Kozlowicz-Reilly A., Leonard S.,
RA   Rohlfing T., Rock S.M., Tin-Wollam A.-M., Abbott A., Minx P., Maupin R.,
RA   Strowmatt C., Latreille P., Miller N., Johnson D., Murray J.,
RA   Woessner J.P., Wendl M.C., Yang S.-P., Schultz B.R., Wallis J.W.,
RA   Spieth J., Bieri T.A., Nelson J.O., Berkowicz N., Wohldmann P.E.,
RA   Cook L.L., Hickenbotham M.T., Eldred J., Williams D., Bedell J.A.,
RA   Mardis E.R., Clifton S.W., Chissoe S.L., Marra M.A., Raymond C., Haugen E.,
RA   Gillett W., Zhou Y., James R., Phelps K., Iadanoto S., Bubb K., Simms E.,
RA   Levy R., Clendenning J., Kaul R., Kent W.J., Furey T.S., Baertsch R.A.,
RA   Brent M.R., Keibler E., Flicek P., Bork P., Suyama M., Bailey J.A.,
RA   Portnoy M.E., Torrents D., Chinwalla A.T., Gish W.R., Eddy S.R.,
RA   McPherson J.D., Olson M.V., Eichler E.E., Green E.D., Waterston R.H.,
RA   Wilson R.K.;
RT   "The DNA sequence of human chromosome 7.";
RL   Nature 424:157-164(2003).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=12690205; DOI=10.1126/science.1083423;
RA   Scherer S.W., Cheung J., MacDonald J.R., Osborne L.R., Nakabayashi K.,
RA   Herbrick J.-A., Carson A.R., Parker-Katiraee L., Skaug J., Khaja R.,
RA   Zhang J., Hudek A.K., Li M., Haddad M., Duggan G.E., Fernandez B.A.,
RA   Kanematsu E., Gentles S., Christopoulos C.C., Choufani S., Kwasnicka D.,
RA   Zheng X.H., Lai Z., Nusskern D.R., Zhang Q., Gu Z., Lu F., Zeesman S.,
RA   Nowaczyk M.J., Teshima I., Chitayat D., Shuman C., Weksberg R.,
RA   Zackai E.H., Grebe T.A., Cox S.R., Kirkpatrick S.J., Rahman N.,
RA   Friedman J.M., Heng H.H.Q., Pelicci P.G., Lo-Coco F., Belloni E.,
RA   Shaffer L.G., Pober B., Morton C.C., Gusella J.F., Bruns G.A.P., Korf B.R.,
RA   Quade B.J., Ligon A.H., Ferguson H., Higgins A.W., Leach N.T.,
RA   Herrick S.R., Lemyre E., Farra C.G., Kim H.-G., Summers A.M., Gripp K.W.,
RA   Roberts W., Szatmari P., Winsor E.J.T., Grzeschik K.-H., Teebi A.,
RA   Minassian B.A., Kere J., Armengol L., Pujana M.A., Estivill X.,
RA   Wilson M.D., Koop B.F., Tosi S., Moore G.E., Boright A.P., Zlotorynski E.,
RA   Kerem B., Kroisel P.M., Petek E., Oscier D.G., Mould S.J., Doehner H.,
RA   Doehner K., Rommens J.M., Vincent J.B., Venter J.C., Li P.W., Mural R.J.,
RA   Adams M.D., Tsui L.-C.;
RT   "Human chromosome 7: DNA sequence and biology.";
RL   Science 300:767-772(2003).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1), AND VARIANT GLY-129.
RC   TISSUE=Lymph, and Placenta;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   PROTEIN SEQUENCE OF 1-17 AND 34-58, ALTERNATIVE SPLICING, IDENTIFICATION IN
RP   THE MSC COMPLEX, INTERACTION WITH TARS3, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY (ISOFORMS 1 AND 2).
RX   PubMed=24312579; DOI=10.1371/journal.pone.0081734;
RA   Kim K., Park S.J., Na S., Kim J.S., Choi H., Kim Y.K., Paek E., Lee C.;
RT   "Reinvestigation of aminoacyl-tRNA synthetase core complex by affinity
RT   purification-mass spectrometry reveals TARSL2 as a potential member of the
RT   complex.";
RL   PLoS ONE 8:E81734-E81734(2013).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 197-320.
RC   TISSUE=Fetal liver;
RA   Zhang C., Yu Y., Zhang S., Wei H., Zhou G., Ouyang S., Luo L., Bi J.,
RA   Liu M., He F.;
RT   "Functional prediction of the coding sequences of 121 new genes deduced by
RT   analysis of cDNA clones from human fetal liver.";
RL   Submitted (DEC-1998) to the EMBL/GenBank/DDBJ databases.
RN   [8]
RP   INTERACTION WITH KARS1.
RX   PubMed=9878398; DOI=10.1006/jmbi.1998.2316;
RA   Quevillon S., Robinson J.-C., Berthonneau E., Siatecka M., Mirande M.;
RT   "Macromolecular assemblage of aminoacyl-tRNA synthetases: identification of
RT   protein-protein interactions and characterization of a core protein.";
RL   J. Mol. Biol. 285:183-195(1999).
RN   [9]
RP   INTERACTION WITH FUBP1.
RX   PubMed=12819782; DOI=10.1038/ng1182;
RA   Kim M.J., Park B.-J., Kang Y.-S., Kim H.J., Park J.-H., Kang J.W.,
RA   Lee S.W., Han J.M., Lee H.-W., Kim S.;
RT   "Downregulation of FUSE-binding protein and c-myc by tRNA synthetase
RT   cofactor p38 is required for lung cell differentiation.";
RL   Nat. Genet. 34:330-336(2003).
RN   [10]
RP   INTERACTION WITH KARS1.
RX   PubMed=15220430; DOI=10.1128/jvi.78.14.7553-7564.2004;
RA   Halwani R., Cen S., Javanbakht H., Saadatmand J., Kim S., Shiba K.,
RA   Kleiman L.;
RT   "Cellular distribution of Lysyl-tRNA synthetase and its interaction with
RT   Gag during human immunodeficiency virus type 1 assembly.";
RL   J. Virol. 78:7553-7564(2004).
RN   [11]
RP   FUNCTION, INTERACTION WITH PRKN, AND UBIQUITINATION.
RX   PubMed=16135753; DOI=10.1523/jneurosci.2172-05.2005;
RA   Ko H.S., von Coelln R., Sriram S.R., Kim S.W., Chung K.K.K., Pletnikova O.,
RA   Troncoso J., Johnson B., Saffary R., Goh E.L., Song H., Park B.-J.,
RA   Kim M.J., Kim S., Dawson V.L., Dawson T.M.;
RT   "Accumulation of the authentic parkin substrate aminoacyl-tRNA synthetase
RT   cofactor, p38/JTV-1, leads to catecholaminergic cell death.";
RL   J. Neurosci. 25:7968-7978(2005).
RN   [12]
RP   INTERACTION WITH KARS1.
RX   PubMed=18029264; DOI=10.1016/j.bbrc.2007.11.028;
RA   Guzzo C.M., Yang D.C.H.;
RT   "Lysyl-tRNA synthetase interacts with EF1alpha, aspartyl-tRNA synthetase
RT   and p38 in vitro.";
RL   Biochem. Biophys. Res. Commun. 365:718-723(2008).
RN   [13]
RP   INTERACTION WITH TP53, VARIANTS VAL-92; 97-GLU--THR-99 DELINS ASP-LEU-SER
RP   AND SER-209, AND MUTAGENESIS OF 163-GLU-ASN-164 AND 172-GLN-ASN-173.
RX   PubMed=18695251; DOI=10.1073/pnas.0800297105;
RA   Han J.M., Park B.-J., Park S.G., Oh Y.S., Choi S.J., Lee S.W., Hwang S.-K.,
RA   Chang S.-H., Cho M.-H., Kim S.;
RT   "AIMP2/p38, the scaffold for the multi-tRNA synthetase complex, responds to
RT   genotoxic stresses via p53.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:11206-11211(2008).
RN   [14]
RP   FUNCTION, SUBUNIT, AND IDENTIFICATION BY MASS SPECTROMETRY.
RX   PubMed=19131329; DOI=10.1074/jbc.m809636200;
RA   Kaminska M., Havrylenko S., Decottignies P., Gillet S., Le Marechal P.,
RA   Negrutskii B., Mirande M.;
RT   "Dissection of the structural organization of the aminoacyl-tRNA synthetase
RT   complex.";
RL   J. Biol. Chem. 284:6053-6060(2009).
RN   [15]
RP   SUBCELLULAR LOCATION, AND SUBUNIT.
RX   PubMed=19289464; DOI=10.1074/jbc.m900480200;
RA   Kaminska M., Havrylenko S., Decottignies P., Le Marechal P., Negrutskii B.,
RA   Mirande M.;
RT   "Dynamic Organization of Aminoacyl-tRNA Synthetase Complexes in the
RT   Cytoplasm of Human Cells.";
RL   J. Biol. Chem. 284:13746-13754(2009).
RN   [16]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T.,
RA   Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [17]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D., Wang L.,
RA   Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human liver
RT   phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [18] {ECO:0007744|PDB:4DPG}
RP   X-RAY CRYSTALLOGRAPHY (2.84 ANGSTROMS) OF 1-48 IN COMPLEX WITH KARS1, AND
RP   SUBUNIT.
RX   PubMed=23159739; DOI=10.1016/j.molcel.2012.10.010;
RA   Ofir-Birin Y., Fang P., Bennett S.P., Zhang H.M., Wang J., Rachmin I.,
RA   Shapiro R., Song J., Dagan A., Pozo J., Kim S., Marshall A.G., Schimmel P.,
RA   Yang X.L., Nechushtan H., Razin E., Guo M.;
RT   "Structural switch of lysyl-tRNA synthetase between translation and
RT   transcription.";
RL   Mol. Cell 49:30-42(2013).
RN   [19] {ECO:0007744|PDB:4YCU, ECO:0007744|PDB:4YCW}
RP   X-RAY CRYSTALLOGRAPHY (2.10 ANGSTROMS) OF 1-36 IN COMPLEX WITH KARS1.
RX   PubMed=26074468; DOI=10.1016/j.chembiol.2015.05.007;
RA   Fang P., Han H., Wang J., Chen K., Chen X., Guo M.;
RT   "Structural Basis for Specific Inhibition of tRNA Synthetase by an ATP
RT   Competitive Inhibitor.";
RL   Chem. Biol. 22:734-744(2015).
RN   [20] {ECO:0007744|PDB:5A34}
RP   X-RAY CRYSTALLOGRAPHY (2.60 ANGSTROMS) OF 90-320 IN COMPLEX WITH EPRS1,
RP   SUBUNIT, AND MUTAGENESIS OF ARG-215 AND ASP-238.
RX   PubMed=26472928; DOI=10.1074/jbc.m115.690867;
RA   Cho H.Y., Maeng S.J., Cho H.J., Choi Y.S., Chung J.M., Lee S., Kim H.K.,
RA   Kim J.H., Eom C.Y., Kim Y.G., Guo M., Jung H.S., Kang B.S., Kim S.;
RT   "Assembly of Multi-tRNA Synthetase Complex via Heterotetrameric Glutathione
RT   Transferase-homology Domains.";
RL   J. Biol. Chem. 290:29313-29328(2015).
RN   [21]
RP   INVOLVEMENT IN HLD17, AND VARIANT HLD17 35-TYR--LYS-320 DEL.
RX   PubMed=29215095; DOI=10.1038/s10038-017-0363-1;
RA   Shukla A., Das Bhowmik A., Hebbar M., Rajagopal K.V., Girisha K.M.,
RA   Gupta N., Dalal A.;
RT   "Homozygosity for a nonsense variant in AIMP2 is associated with a
RT   progressive neurodevelopmental disorder with microcephaly, seizures, and
RT   spastic quadriparesis.";
RL   J. Hum. Genet. 63:19-25(2018).
CC   -!- FUNCTION: Required for assembly and stability of the aminoacyl-tRNA
CC       synthase complex (PubMed:19131329). Mediates ubiquitination and
CC       degradation of FUBP1, a transcriptional activator of MYC, leading to
CC       MYC down-regulation which is required for aveolar type II cell
CC       differentiation. Blocks MDM2-mediated ubiquitination and degradation of
CC       p53/TP53. Functions as a proapoptotic factor.
CC       {ECO:0000269|PubMed:16135753, ECO:0000269|PubMed:19131329}.
CC   -!- SUBUNIT: Part of the multisynthetase complex (MSC), a multisubunit
CC       complex that groups tRNA ligases for Arg (RARS1), Asp (DARS1), Gln
CC       (QARS1), Ile (IARS1), Leu (LARS1), Lys (KARS1), Met (MARS1) the
CC       bifunctional ligase for Glu and Pro (EPRS1) and the auxiliary subunits
CC       AIMP1/p43, AIMP2/p38 and EEF1E1/p18 (PubMed:19131329, PubMed:19289464,
CC       PubMed:24312579). Interacts (via N-terminus) with KARS1
CC       (PubMed:15220430, PubMed:18029264, PubMed:23159739, PubMed:26074468,
CC       PubMed:9878398). Interacts with EPRS1 (PubMed:26472928). Forms a linear
CC       complex that contains MARS1, EEF1E1, EPRS1 and AIMP2 that is at the
CC       core of the multisubunit complex (PubMed:26472928). Binds FUBP1 (via C-
CC       terminus). Interacts in both its unphosphorylated and phosphorylated
CC       forms with p53/TP53 (via N-terminus) in the nucleus following UV
CC       irradiation. Interacts (via N-terminus) with PRKN/parkin (via first
CC       RING-type domain) (PubMed:16135753). Interacts with TARS3
CC       (PubMed:24312579). {ECO:0000269|PubMed:12819782,
CC       ECO:0000269|PubMed:15220430, ECO:0000269|PubMed:16135753,
CC       ECO:0000269|PubMed:18029264, ECO:0000269|PubMed:18695251,
CC       ECO:0000269|PubMed:19131329, ECO:0000269|PubMed:19289464,
CC       ECO:0000269|PubMed:23159739, ECO:0000269|PubMed:24312579,
CC       ECO:0000269|PubMed:26074468, ECO:0000269|PubMed:26472928,
CC       ECO:0000269|PubMed:9878398}.
CC   -!- INTERACTION:
CC       Q13155; Q12904: AIMP1; NbExp=5; IntAct=EBI-745226, EBI-1045802;
CC       Q13155; Q12904-2: AIMP1; NbExp=5; IntAct=EBI-745226, EBI-12412735;
CC       Q13155; P05067: APP; NbExp=3; IntAct=EBI-745226, EBI-77613;
CC       Q13155; O75934: BCAS2; NbExp=12; IntAct=EBI-745226, EBI-1050106;
CC       Q13155; Q0VDD7: BRME1; NbExp=8; IntAct=EBI-745226, EBI-741210;
CC       Q13155; Q13895: BYSL; NbExp=5; IntAct=EBI-745226, EBI-358049;
CC       Q13155; Q8TAB5: C1orf216; NbExp=3; IntAct=EBI-745226, EBI-747505;
CC       Q13155; Q8NA61-2: CBY2; NbExp=5; IntAct=EBI-745226, EBI-11524851;
CC       Q13155; Q96L14: CEP170P1; NbExp=5; IntAct=EBI-745226, EBI-743488;
CC       Q13155; P14868: DARS1; NbExp=10; IntAct=EBI-745226, EBI-358730;
CC       Q13155; Q9NRI5-2: DISC1; NbExp=3; IntAct=EBI-745226, EBI-11988027;
CC       Q13155; Q494R4-2: DRC12; NbExp=3; IntAct=EBI-745226, EBI-11974185;
CC       Q13155; Q8IYI6: EXOC8; NbExp=5; IntAct=EBI-745226, EBI-742102;
CC       Q13155; Q13643: FHL3; NbExp=13; IntAct=EBI-745226, EBI-741101;
CC       Q13155; Q96AE4: FUBP1; NbExp=4; IntAct=EBI-745226, EBI-711404;
CC       Q13155; P13807: GYS1; NbExp=3; IntAct=EBI-745226, EBI-740553;
CC       Q13155; Q15046: KARS1; NbExp=23; IntAct=EBI-745226, EBI-356367;
CC       Q13155; Q15046-1: KARS1; NbExp=2; IntAct=EBI-745226, EBI-21457670;
CC       Q13155; Q15323: KRT31; NbExp=3; IntAct=EBI-745226, EBI-948001;
CC       Q13155; Q14525: KRT33B; NbExp=3; IntAct=EBI-745226, EBI-1049638;
CC       Q13155; O76011: KRT34; NbExp=3; IntAct=EBI-745226, EBI-1047093;
CC       Q13155; O76013-2: KRT36; NbExp=3; IntAct=EBI-745226, EBI-11958506;
CC       Q13155; P25791: LMO2; NbExp=3; IntAct=EBI-745226, EBI-739696;
CC       Q13155; P25791-3: LMO2; NbExp=6; IntAct=EBI-745226, EBI-11959475;
CC       Q13155; Q8TBB1: LNX1; NbExp=8; IntAct=EBI-745226, EBI-739832;
CC       Q13155; Q9NYP9: MIS18A; NbExp=6; IntAct=EBI-745226, EBI-1104552;
CC       Q13155; Q9GZM8: NDEL1; NbExp=3; IntAct=EBI-745226, EBI-928842;
CC       Q13155; Q7Z6G3-2: NECAB2; NbExp=3; IntAct=EBI-745226, EBI-10172876;
CC       Q13155; Q96HA8: NTAQ1; NbExp=3; IntAct=EBI-745226, EBI-741158;
CC       Q13155; P22061: PCMT1; NbExp=3; IntAct=EBI-745226, EBI-353343;
CC       Q13155; O15212: PFDN6; NbExp=3; IntAct=EBI-745226, EBI-356973;
CC       Q13155; Q9H8W4: PLEKHF2; NbExp=3; IntAct=EBI-745226, EBI-742388;
CC       Q13155; P54646: PRKAA2; NbExp=3; IntAct=EBI-745226, EBI-1383852;
CC       Q13155; Q15276: RABEP1; NbExp=3; IntAct=EBI-745226, EBI-447043;
CC       Q13155; P0C264: SBK3; NbExp=3; IntAct=EBI-745226, EBI-17181801;
CC       Q13155; O95391: SLU7; NbExp=3; IntAct=EBI-745226, EBI-750559;
CC       Q13155; Q8TC71: SPATA18; NbExp=3; IntAct=EBI-745226, EBI-11334239;
CC       Q13155; Q8WWU5-7: TCP11; NbExp=3; IntAct=EBI-745226, EBI-17721485;
CC       Q13155; Q9NYB0: TERF2IP; NbExp=2; IntAct=EBI-745226, EBI-750109;
CC       Q13155; Q9BXU0: TEX12; NbExp=3; IntAct=EBI-745226, EBI-12090309;
CC       Q13155; Q9UBB9: TFIP11; NbExp=6; IntAct=EBI-745226, EBI-1105213;
CC       Q13155; P04637: TP53; NbExp=6; IntAct=EBI-745226, EBI-366083;
CC       Q13155; A0A0S2Z6H0: ZGPAT; NbExp=3; IntAct=EBI-745226, EBI-16428984;
CC       Q13155; Q8N5A5: ZGPAT; NbExp=3; IntAct=EBI-745226, EBI-3439227;
CC       Q13155; Q8N5A5-2: ZGPAT; NbExp=12; IntAct=EBI-745226, EBI-10183064;
CC       Q13155; PRO_0000038593 [P04591]: gag; Xeno; NbExp=3; IntAct=EBI-745226, EBI-6179719;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm, cytosol {ECO:0000269|PubMed:19289464}.
CC       Nucleus {ECO:0000250|UniProtKB:Q8R010}. Note=Following DNA damage,
CC       dissociates from the aminoacyl-tRNA synthase complex and translocates
CC       from the cytoplasm to the nucleus. {ECO:0000250|UniProtKB:Q8R010}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q13155-1; Sequence=Displayed;
CC       Name=2; Synonyms=DX2 {ECO:0000303|PubMed:24312579};
CC         IsoId=Q13155-2; Sequence=VSP_059914;
CC   -!- PTM: Phosphorylated on serine residues in response to UV irradiation.
CC       {ECO:0000250}.
CC   -!- PTM: Ubiquitinated by PRKN, leading to its degradation by the
CC       proteasome. Mutant PRKN fails to ubiquitinate AIMP2 efficiently,
CC       allowing its accumulation which may contribute to neurodegeneration
CC       associated with Parkinson disease. {ECO:0000269|PubMed:16135753}.
CC   -!- DISEASE: Leukodystrophy, hypomyelinating, 17 (HLD17) [MIM:618006]: An
CC       autosomal recessive neurodevelopmental disorder characterized by
CC       atrophy of cerebral cortex, spinal cord and cerebellum, thin corpus
CC       callosum, abnormal signals in the basal ganglia, and features
CC       suggesting hypo- or demyelination observed on brain imaging. Clinical
CC       manifestations include lack of development, absent speech,
CC       microcephaly, spasticity, seizures, and contractures.
CC       {ECO:0000269|PubMed:29215095}. Note=The disease may be caused by
CC       variants affecting the gene represented in this entry.
CC   -!- MISCELLANEOUS: Accumulates in brains affected by autosomal-recessive
CC       juvenile parkinsonism, idiopathic Parkinson disease and diffuse Lewy
CC       body disease.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAC50391.1; Type=Frameshift; Evidence={ECO:0000305};
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; U24169; AAC50391.1; ALT_FRAME; mRNA.
DR   EMBL; AC005995; AAS00389.1; -; Genomic_DNA.
DR   EMBL; CH236963; EAL23713.1; -; Genomic_DNA.
DR   EMBL; CH878731; EAW55053.1; -; Genomic_DNA.
DR   EMBL; BC002853; AAH02853.1; -; mRNA.
DR   EMBL; BC010156; AAH10156.1; -; mRNA.
DR   EMBL; BC013630; AAH13630.1; -; mRNA.
DR   EMBL; AF116615; AAF71039.1; -; mRNA.
DR   CCDS; CCDS5344.1; -. [Q13155-1]
DR   CCDS; CCDS87475.1; -. [Q13155-2]
DR   RefSeq; NP_001313536.1; NM_001326607.2. [Q13155-2]
DR   RefSeq; NP_006294.2; NM_006303.3. [Q13155-1]
DR   PDB; 4DPG; X-ray; 2.84 A; I/J/K/L=1-48.
DR   PDB; 4YCU; X-ray; 2.10 A; C=1-36.
DR   PDB; 4YCW; X-ray; 2.90 A; C/D/G/H=1-36.
DR   PDB; 5A1N; X-ray; 2.10 A; B=90-320.
DR   PDB; 5A34; X-ray; 2.60 A; B/D/F/H=90-320.
DR   PDB; 5A5H; X-ray; 2.32 A; B/D/F/H=90-320.
DR   PDB; 5Y6L; X-ray; 2.90 A; D=89-320.
DR   PDB; 6ILD; X-ray; 1.88 A; C=1-36.
DR   PDB; 6IY6; X-ray; 3.60 A; C/D/I/J=115-320.
DR   PDB; 6JPV; X-ray; 2.15 A; A/B=24-32.
DR   PDB; 6K39; X-ray; 1.40 A; A/B=25-32.
DR   PDB; 8J9S; X-ray; 3.01 A; C=50-90.
DR   PDB; 9DPL; EM; 2.80 A; D/E=1-36.
DR   PDBsum; 4DPG; -.
DR   PDBsum; 4YCU; -.
DR   PDBsum; 4YCW; -.
DR   PDBsum; 5A1N; -.
DR   PDBsum; 5A34; -.
DR   PDBsum; 5A5H; -.
DR   PDBsum; 5Y6L; -.
DR   PDBsum; 6ILD; -.
DR   PDBsum; 6IY6; -.
DR   PDBsum; 6JPV; -.
DR   PDBsum; 6K39; -.
DR   PDBsum; 8J9S; -.
DR   PDBsum; 9DPL; -.
DR   AlphaFoldDB; Q13155; -.
DR   EMDB; EMD-47106; -.
DR   SMR; Q13155; -.
DR   BioGRID; 113684; 455.
DR   ComplexPortal; CPX-2469; Multiaminoacyl-tRNA synthetase complex.
DR   CORUM; Q13155; -.
DR   DIP; DIP-34421N; -.
DR   FunCoup; Q13155; 619.
DR   IntAct; Q13155; 104.
DR   MINT; Q13155; -.
DR   STRING; 9606.ENSP00000223029; -.
DR   BindingDB; Q13155; -.
DR   ChEMBL; CHEMBL4523285; -.
DR   GlyGen; Q13155; 1 site, 1 O-linked glycan (1 site).
DR   iPTMnet; Q13155; -.
DR   PhosphoSitePlus; Q13155; -.
DR   SwissPalm; Q13155; -.
DR   BioMuta; AIMP2; -.
DR   jPOST; Q13155; -.
DR   MassIVE; Q13155; -.
DR   PaxDb; 9606-ENSP00000223029; -.
DR   PeptideAtlas; Q13155; -.
DR   ProteomicsDB; 30261; -.
DR   ProteomicsDB; 59195; -.
DR   Pumba; Q13155; -.
DR   ABCD; Q13155; 1 sequenced antibody.
DR   Antibodypedia; 11563; 206 antibodies from 32 providers.
DR   DNASU; 7965; -.
DR   Ensembl; ENST00000223029.8; ENSP00000223029.3; ENSG00000106305.10. [Q13155-1]
DR   Ensembl; ENST00000395236.2; ENSP00000378658.2; ENSG00000106305.10. [Q13155-2]
DR   GeneID; 7965; -.
DR   KEGG; hsa:7965; -.
DR   MANE-Select; ENST00000223029.8; ENSP00000223029.3; NM_006303.4; NP_006294.2.
DR   UCSC; uc003spo.4; human. [Q13155-1]
DR   AGR; HGNC:20609; -.
DR   CTD; 7965; -.
DR   DisGeNET; 7965; -.
DR   GeneCards; AIMP2; -.
DR   HGNC; HGNC:20609; AIMP2.
DR   HPA; ENSG00000106305; Tissue enhanced (skeletal).
DR   MalaCards; AIMP2; -.
DR   MIM; 600859; gene.
DR   MIM; 618006; phenotype.
DR   OpenTargets; ENSG00000106305; -.
DR   VEuPathDB; HostDB:ENSG00000106305; -.
DR   eggNOG; ENOG502QUNJ; Eukaryota.
DR   GeneTree; ENSGT00390000015826; -.
DR   HOGENOM; CLU_076114_0_0_1; -.
DR   InParanoid; Q13155; -.
DR   OMA; LCQHYRV; -.
DR   OrthoDB; 2309723at2759; -.
DR   PAN-GO; Q13155; 2 GO annotations based on evolutionary models.
DR   PhylomeDB; Q13155; -.
DR   PathwayCommons; Q13155; -.
DR   Reactome; R-HSA-2408522; Selenoamino acid metabolism.
DR   Reactome; R-HSA-379716; Cytosolic tRNA aminoacylation.
DR   Reactome; R-HSA-9856649; Transcriptional and post-translational regulation of MITF-M expression and activity.
DR   SignaLink; Q13155; -.
DR   SIGNOR; Q13155; -.
DR   BioGRID-ORCS; 7965; 17 hits in 1160 CRISPR screens.
DR   CD-CODE; DEE660B4; Stress granule.
DR   ChiTaRS; AIMP2; human.
DR   EvolutionaryTrace; Q13155; -.
DR   GeneWiki; Multisynthetase_complex_auxiliary_component_p38; -.
DR   GenomeRNAi; 7965; -.
DR   Pharos; Q13155; Tchem.
DR   PRO; PR:Q13155; -.
DR   Proteomes; UP000005640; Chromosome 7.
DR   RNAct; Q13155; protein.
DR   Bgee; ENSG00000106305; Expressed in oocyte and 219 other cell types or tissues.
DR   ExpressionAtlas; Q13155; baseline and differential.
DR   GO; GO:0017101; C:aminoacyl-tRNA synthetase multienzyme complex; IDA:UniProtKB.
DR   GO; GO:0005829; C:cytosol; IDA:UniProtKB.
DR   GO; GO:0016020; C:membrane; HDA:UniProtKB.
DR   GO; GO:0005634; C:nucleus; IEA:UniProtKB-SubCell.
DR   GO; GO:0060090; F:molecular adaptor activity; IEA:Ensembl.
DR   GO; GO:0006915; P:apoptotic process; IEA:UniProtKB-KW.
DR   GO; GO:0008285; P:negative regulation of cell population proliferation; IEA:Ensembl.
DR   GO; GO:0043525; P:positive regulation of neuron apoptotic process; IEA:Ensembl.
DR   GO; GO:0031398; P:positive regulation of protein ubiquitination; IEA:Ensembl.
DR   GO; GO:0016567; P:protein ubiquitination; IEA:Ensembl.
DR   GO; GO:0065003; P:protein-containing complex assembly; IEA:Ensembl.
DR   GO; GO:0006412; P:translation; IEA:UniProtKB-KW.
DR   GO; GO:0060510; P:type II pneumocyte differentiation; IEA:Ensembl.
DR   CDD; cd03200; GST_C_AIMP2; 1.
DR   FunFam; 1.20.1050.130:FF:000002; aminoacyl tRNA synthase complex-interacting multifunctional protein 2 isoform X2; 1.
DR   Gene3D; 1.20.1050.130; -; 1.
DR   InterPro; IPR042360; AIMP2.
DR   InterPro; IPR031889; AIMP2_LysRS-bd.
DR   InterPro; IPR041503; AIMP2_thioredoxin.
DR   InterPro; IPR036282; Glutathione-S-Trfase_C_sf.
DR   InterPro; IPR004046; GST_C.
DR   PANTHER; PTHR13438; AMINOACYL TRNA SYNTHASE COMPLEX-INTERACTING MULTIFUNCTIONAL PROTEIN; 1.
DR   PANTHER; PTHR13438:SF2; AMINOACYL TRNA SYNTHASE COMPLEX-INTERACTING MULTIFUNCTIONAL PROTEIN 2; 1.
DR   Pfam; PF16780; AIMP2_LysRS_bd; 1.
DR   Pfam; PF00043; GST_C; 1.
DR   Pfam; PF18569; Thioredoxin_16; 1.
DR   SUPFAM; SSF47616; GST C-terminal domain-like; 1.
DR   neXtProt; NX_Q13155; -.
DR   PharmGKB; PA165617609; -.
DR   TreeFam; TF326322; -.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Apoptosis; Cytoplasm;
KW   Developmental protein; Differentiation; Direct protein sequencing;
KW   Disease variant; Leukodystrophy; Nucleus; Phosphoprotein;
KW   Protein biosynthesis; Proteomics identification; Reference proteome;
KW   Ubl conjugation.
FT   CHAIN           1..320
FT                   /note="Aminoacyl tRNA synthase complex-interacting
FT                   multifunctional protein 2"
FT                   /id="PRO_0000221129"
FT   DOMAIN          220..317
FT                   /note="GST C-terminal"
FT   REGION          82..162
FT                   /note="Interaction with PRKN"
FT                   /evidence="ECO:0000269|PubMed:16135753"
FT   REGION          162..225
FT                   /note="Interaction with TP53"
FT                   /evidence="ECO:0000269|PubMed:18695251"
FT   VAR_SEQ         46..114
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000269|PubMed:24312579"
FT                   /id="VSP_059914"
FT   VARIANT         35..320
FT                   /note="Missing (in HLD17)"
FT                   /evidence="ECO:0000269|PubMed:29215095"
FT                   /id="VAR_081108"
FT   VARIANT         92
FT                   /note="I -> V (in a lung cancer cell line; reduced
FT                   interaction with TP53, loss of TP53 activation and loss of
FT                   proapoptotic activity)"
FT                   /evidence="ECO:0000269|PubMed:18695251"
FT                   /id="VAR_058392"
FT   VARIANT         97..99
FT                   /note="EPT -> DLS (in a lung cancer cell line; no effect on
FT                   proapoptotic activity)"
FT                   /evidence="ECO:0000269|PubMed:18695251"
FT                   /id="VAR_058393"
FT   VARIANT         129
FT                   /note="A -> G (in dbSNP:rs17855441)"
FT                   /evidence="ECO:0000269|PubMed:15489334"
FT                   /id="VAR_025521"
FT   VARIANT         166
FT                   /note="L -> I (in dbSNP:rs34525431)"
FT                   /id="VAR_050125"
FT   VARIANT         209
FT                   /note="G -> S (in a lung cancer cell line; no effect on
FT                   proapoptotic activity; dbSNP:rs982080297)"
FT                   /evidence="ECO:0000269|PubMed:18695251"
FT                   /id="VAR_058394"
FT   MUTAGEN         163..164
FT                   /note="EN->AA: Reduced interaction with TP53, loss of TP53
FT                   activation and loss of proapoptotic activity."
FT                   /evidence="ECO:0000269|PubMed:18695251"
FT   MUTAGEN         172..173
FT                   /note="QN->AA: Reduced interaction with TP53, loss of TP53
FT                   activation and loss of proapoptotic activity."
FT                   /evidence="ECO:0000269|PubMed:18695251"
FT   MUTAGEN         215
FT                   /note="R->A: Nearly abolishes interaction with EPRS1."
FT                   /evidence="ECO:0000269|PubMed:26472928"
FT   MUTAGEN         238
FT                   /note="D->R: Nearly abolishes interaction with EPRS1."
FT                   /evidence="ECO:0000269|PubMed:26472928"
FT   STRAND          12..14
FT                   /evidence="ECO:0007829|PDB:6ILD"
FT   HELIX           52..79
FT                   /evidence="ECO:0007829|PDB:8J9S"
FT   HELIX           108..112
FT                   /evidence="ECO:0007829|PDB:5A1N"
FT   HELIX           113..115
FT                   /evidence="ECO:0007829|PDB:5A1N"
FT   HELIX           116..119
FT                   /evidence="ECO:0007829|PDB:5A1N"
FT   STRAND          120..126
FT                   /evidence="ECO:0007829|PDB:5A1N"
FT   STRAND          128..130
FT                   /evidence="ECO:0007829|PDB:5A34"
FT   HELIX           133..143
FT                   /evidence="ECO:0007829|PDB:5A1N"
FT   STRAND          148..154
FT                   /evidence="ECO:0007829|PDB:5A1N"
FT   HELIX           163..166
FT                   /evidence="ECO:0007829|PDB:5A1N"
FT   TURN            167..169
FT                   /evidence="ECO:0007829|PDB:5A5H"
FT   STRAND          182..189
FT                   /evidence="ECO:0007829|PDB:5A1N"
FT   STRAND          196..198
FT                   /evidence="ECO:0007829|PDB:5A1N"
FT   STRAND          202..204
FT                   /evidence="ECO:0007829|PDB:5A5H"
FT   STRAND          207..209
FT                   /evidence="ECO:0007829|PDB:5A5H"
FT   HELIX           210..219
FT                   /evidence="ECO:0007829|PDB:5A1N"
FT   HELIX           227..242
FT                   /evidence="ECO:0007829|PDB:5A1N"
FT   TURN            243..246
FT                   /evidence="ECO:0007829|PDB:5A1N"
FT   HELIX           249..262
FT                   /evidence="ECO:0007829|PDB:5A1N"
FT   TURN            263..265
FT                   /evidence="ECO:0007829|PDB:5A1N"
FT   STRAND          266..268
FT                   /evidence="ECO:0007829|PDB:5A1N"
FT   STRAND          271..273
FT                   /evidence="ECO:0007829|PDB:5A1N"
FT   HELIX           276..286
FT                   /evidence="ECO:0007829|PDB:5A1N"
FT   STRAND          291..293
FT                   /evidence="ECO:0007829|PDB:5Y6L"
FT   HELIX           297..307
FT                   /evidence="ECO:0007829|PDB:5A1N"
FT   HELIX           310..318
FT                   /evidence="ECO:0007829|PDB:5A1N"
SQ   SEQUENCE   320 AA;  35349 MW;  F253726B63C12BAB CRC64;
     MPMYQVKPYH GGGAPLRVEL PTCMYRLPNV HGRSYGPAPG AGHVQEESNL SLQALESRQD
     DILKRLYELK AAVDGLSKMI QTPDADLDVT NIIQADEPTT LTTNALDLNS VLGKDYGALK
     DIVINANPAS PPLSLLVLHR LLCEHFRVLS TVHTHSSVKS VPENLLKCFG EQNKKQPRQD
     YQLGFTLIWK NVPKTQMKFS IQTMCPIEGE GNIARFLFSL FGQKHNAVNA TLIDSWVDIA
     IFQLKEGSSK EKAAVFRSMN SALGKSPWLA GNELTVADVV LWSVLQQIGG CSVTVPANVQ
     RWMRSCENLA PFNTALKLLK
//
